Summaries & Associations of Study Results
TR-422 Coumarin
Target Organs and Levels of Evidence
NTP Technical Report Number 422
Produced from Chemtrack Database 09/19/01
CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
---|---|---|---|---|
COUMARIN 91-64-5 |
06/23/92 | ODOR ENHANCING AGENT IN PERFUMES. PHARMACEUTIC AID (FLAVOR). (TDB) | Gavage R: 0,25,50,100; M: 0,50,100,200 MG/KG/60 & 70 PER GROUP RESPECTIVELY | American Biogenics Corp (Bioassay Systems) |
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
MR: SOME EVIDENCE | KIDNEY TUBULAR CELL: ADENOMA 1/49 2/50 2/51 1/50, STEP SECTIONS 0/49 4/50 5/51 4/50 | |||
NON-NEOPLASTIC LESIONS: | LIVER: CYTOLOGIC ALTERATIONS; FIBROSIS; NECROSIS; BILE DUCT HYPERPLASIA | |||
FORESTOMACH: ULCER | ||||
PARATHYROID GLAND: HYPERPLASIA | ||||
KIDNEY: INCREASED SEVERITY OF NEPHROPATHY | ||||
FR: EQUIVOCAL EVIDENCE | KIDNEY TUBULAR CELL: ADENOMA 0/49 0/50 0/50 2/49, STEP SECTIONS 0/49 0/50 1/50 1/49 | |||
NON-NEOPLASTIC LESIONS: | LIVER: FIBROSIS; NECROSIS; DEGENERATION; BILE DUCT HYPERPLASIA | |||
FORESTOMACH: ULCER | ||||
KIDNEY: INCREASED SEVERITY OF NEPHROPATHY | ||||
MM: SOME EVIDENCE | LUNG: ALVEOLAR/BRONCHIOLAR ADENOMA 14/50 8/50 14/50 24/51 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 1/50 2/50 1/51 COMBINED 14/50 9/50 15/50 25/51 | |||
MAY HAVE BEEN RELATED: | FORESTOMACH: SQUAMOUS CELL PAPILLOMA 2/50 8/50 2/50 0/51 | |||
NON-NEOPLASTIC LESIONS: | LIVER: SYNCYTIAL ALTERATION; CENTRILOBULAR HYPERTROPHY; EOSINOPHILIC FOCUS | |||
FM: CLEAR EVIDENCE | LUNG: ALVEOLAR/BRONCHIOLAR ADENOMA 2/51 5/49 7/49 20/51 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/51 0/49 0/49 7/51 COMBINED 2/51 5/49 7/49 27/51 | |||
LIVER: ADENOMA 8/50 26/49 29/51 12/50 | ||||
MAY HAVE BEEN RELATED: | FORESTOMACH: SQUAMOUS CELL PAPILLOMA 1/52 5/50 2/51 2/51 | |||
NON-NEOPLASTIC LESIONS: | LIVER: SYNCYTIAL ALTERATION; CENTRILOBULAR HYPERTROPHY; EOSINOPHILIC FOCUS |
Web page last updated on February 10, 2006